Methylene blue as drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass [2] (multiple letters)

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 3, 2004, Pages 895-896

  Evora, Paulo Roberto B ^a   Levin, Ricardo L ^b   Leyh, R G ^c   Kofidis, T ^c   Struber, M ^c   Fischer, S ^c   Knobloch, K ^c   Wachsmann, B ^c   Hagl, C ^c   Simon, A R ^c   Haverich, A ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Navy Hospital   (Argentina)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; CATECHOLAMINE; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; NORADRENALIN; PROTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BOLUS INJECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM INJURY; HUMAN; LETTER; LIVER TRANSPLANTATION; MEAN ARTERIAL PRESSURE; NONHUMAN; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; SYNDROME DELINEATION; VASOPLEGIA SYNDROME;

EID: 12144289147     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.09.046     Document Type: Letter

References (5)

1. R.G Leyh T Kofidis M Struber S Fischer K Knobloch B Wachsmann Methylene blue the drug of choice for catecholamine-3 refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 125 2003 1426 1431
2. P.R Evora P.J Ribeiro J.C de Andrade Methylene blue administration in SIRS after cardiac operations Ann Thorac Surg 63 1997 1212 1213
3. M Grayling C.D Deakin Methylene blue during cardiopulmonary bypass to treat refractory hypotension in septic endocarditis J Thorac Cardiovasc Surg 125 2003 426 427
4. R.L Levin M.A Degrange J Bilbao Sindrome vasoplejico en postoperatorio de cirugia cardiaca. Reduccion de la mortalidad mediante el empleo de azul de metileno Rev Argent Cardiol 69 2001 524 529
5. W.J Gomes A.C Carvalho J.H Palma Vasoplegic syndrome a new dilemma J Thorac Cardiovasc Surg 107 1994 942 943